China SXT Pharmaceuticals【SXTC】銘柄情報

China SXT Pharmaceuticals Inc (SXTC) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.58

( 9.72% )

買値

1.52

売値

1.57

出来高

85,459

1.46 日の範囲 1.63

0.0267 52 週間の範囲 6.9799

時価総額

10.204M

前日終値

1.44

始値

1.47

時刻

1.52

最終取引時間

03:07:20

財務取引量

US$ 131,568

VWAP

1.5395

平均取引量 (3 か月)

US$ 52,447

発行済株式数

6,458,077

配当利回り

PER

-0.06

1 株当たり利益 (EPS)

-22.46

歳入

1.54M

純利益

-8.87M

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi... China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.sxtchina.com

本社

Taizhou, China

設立

2026

China SXT Pharmaceuticals Inc is listed in the Healthcare sector of the ナスダック市場 with ticker SXTC. The last closing price for China SXT Pharmaceuticals was US$1.44. Over the last year, China SXT Pharmaceuticals shares have traded in a share price range of US$ 0.0267 to US$ 6.9799.

China SXT Pharmaceuticals currently has 6,458,077 shares in issue. The market capitalisation of China SXT Pharmaceuticals is US$10.20 million. China SXT Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.06.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 3 - Initial statement of beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.04	-2.46913580247	1.62	1.85	1.41	73169	1.65836693	CS
4	-0.12	-7.05882352941	1.7	1.85	1.41	36410	1.63894033	CS
12	-0.38	-19.387755102	1.96	2.58	1.2501	54307	1.76894888	CS
26	0.18	12.8571428571	1.4	6.9799	0.0267	11824498	0.18055826	CS
52	-0.49	-23.6714975845	2.07	6.9799	0.0267	5980893	0.20809637	CS
156	1.354	599.115044248	0.226	6.9799	0.0267	3135294	0.57639925	CS
260	0.09	6.04026845638	1.49	6.9799	0.0267	2718544	0.5762596	CS